Standalone Financial Results, Form A, Auditors Report For March 31, 2016 (Result)

s?"Sword & Shield Pharma Ltd.
.....
CIN: L24231 GJ1995P C024809
Date: May 30, 2016.

To,
BSE Limited
Phiroze Jeejeebhoy Towers,

Dalal Street,
Mumbai- 400 001.
Dear Sir,
Sub: Outcome of Board meeting held on May 30,2016.
Ref: Sword and Shield Pharma Limited.
(Security Id/Code:SWORDNSH/531637)
Pursuant
to
Regulation
30
of
the
SEBI
(Listing
Obligations
and
Disclosure,.
Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of
the Company, in their meeting held on today i.e. May 30, 2016 at the Registered Office of
the Company, have considered following matters:
1.
The Board of Directors have inter alia considered, approved and taken on record
the Audited Financial Results of the Company along with Report of the Auditor
thereon and Form A for the Quarter and Year ended on March 31, 2016.
The meeting of the Board of Directors was started at 4.00 P.M. and concluded at 05.45
P.M.
The statement of Audited Financial Results of the Company along with the Report of the
Auditor submitted by the Statutory Auditors of the Company and Form A has been
attached herewith.
Kindly take the same on your record and oblige us.
,..
Managing Director
DIN:01877446
Registered Office:
.
206, Shant1 Arcade, Near Akash Ill, 132 Ft. Ring Road, Naranpura
. Ahmedabad 380 013. Phone: 079 274305941 95
E-mail : swordnshield1995@gmail.com Website : wlivw.swo
rdnshieldpharma.com
SWORD AND SHIELD PHARMA LTD

CIN: l24231GJ1995PLC024809
Registered Office: 206, Shanti Arcade, Near Akash-111, 132 ft. Ring Road, Naranpura, Ahmedabad - 380 013.
Website: www.swordnshieldpharma.com
STATEMENT OF AUDITED FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED MARCH 31,2016
[Amount in (Rs.)]
''l!
Th
Previous 3 months
3 months ended
pJ:rticulars
ended
(dd-mm-YYY'()
(dd-mm-yyyy)
i'
Corresponding 3
Year'tO date figures
Year t9:date figures
months ended in
for current period
for previous period
the previous year
ended
ended
Previous accountin g
year ended
(dd-mm-yyyy)
(dd-mm-yyyy)
(dd-mm-yyyy)
(dd-mm-yyyy)
Date of start of reporting quarter
01-01-2016
01-1Q-2015
01-01-2015
01-04-2015
01-042014
01-04-2014
Date of end of reporting quarter
31-03-2016
31-12-2015
31-03-2015
31-03-2016
31-03-2015
31-03-2015
Audited
Unaudited
Audited
Audited
Audited
Audited
Standalone
Standalone
Standalone
Standalone
Standalone
Standalone
Whether results are a'udited or unaudited
Nature of report standalone or consolidated

Part I
Revenue From Operations
Net sales or Revenue from Operations
0,000
0.000
1165412.000
381.000
12254601.000
Other operating revenues
0.000
0.000
0.000
0.000
0.000
0.000
Total Revenue from operations (net)

2
(a)
(b)
(c)
(d)
(e)
0.000
0.000
1165412.ooo
381.000
12254601.000
12254601.000
Cost of materials consumed
0.000
0.000
359272.000
534639.000
5794522.000
5794522.000
Purchases of stock-in-trade
0.000
0.000
0.000
0.000
0.000
0.000
Changes in inventories of finished goods, work-in-progress and stock-in-trade
0.000
0.000
290111.000
0.000
499501.000
499501.000
595305.000
552900.000
1241125.000
2291907.000
3943468.000
3943468.000
74282.000
428172.000
892572.000
1352053.000
3619876.000
3619876.000
881714.000
102789.000
990370.000
1731236.000
1671765.000
1671765.000
881714.000
102789.000
990370.000
1731236.000
1671765.000
1671765.000
1551301.000
1083861.000
3773450.000
5909835.000
15529132.000
15529132.000
-1551301.000
-1083861.000
-2608038.000
-5909454.000
-3274531.000
-3274531.000
270000.000
856800.000
388340.000
3231035.000
398934.000
398934.000
Profit (loss) from ordinary activates before finance costs and exceptional items
-1281301.000
-227061.000
-2219698.000
-2678419.000
-2875597.000
-2875597.000
0.000
0.000
0.000
0.000
0.000
0.000
Profit (loss) from ordinary activities after finance costs but before exceptional items
-1281301.000
-227061.000
-2219698.000
-2678419.000
-2875597.000
-2875597.000
0.000 ----0.000
---0.000
-187394.000
-300011.000
-- ------0.000
0.000
. --202394.000
-202394.000
-3077991.000
Expenses
Employee benefit expense
(f)
1
Depreciation and amortisation expense

Other Expenses
OTHER EXPENSES
'
Total other expenses

Total expenses
3
4
Profit (loss) from operations before other income, finance costs and exceptional items
Other income
5
6
7
Finance costs
r_!?.period ite!ort:
Exceptional items
--- -
- --
Profit (loss) from ordinary activities before tax
-300011.000
-----0.000
----.-- --
0.000
-227061.000
-2407092.000
-2978430.000
-3077991.000
0.000
-132305.000
-559133.000
0.000
-714981.000
-714981.000
Net profit (loss) from ordinary activities after tax
-1581312.000
-94756.000
-1847959.000
-2978430.000
-2363010.000
-2363010.000
0.000
0.000
0.000
0.000
0.000
0.000
14
Net Profit loss for the period from continuing operations
-1581312.000
-94756.000
-1847959.000
-2978430.000
-2363010.000
-2363010.000
15
Profit (loss) from discontinuing opertions before tax
5262783.000
0.000
0.000
5262783.000
0.000
0.000
16
Tax expense of discontinuing operations
0.000
0.000
0.000
0.000
0.000
0.000
Net profit (loss) from discontinuing operation after tax
5262783.000
0.000
0.000
5262783.000
0.000
0.000
Profit (loss) for period before minority interest
3681471.000
-94756.000
-1847959.000
2284353.000
-2363010.000
-2363010.000
3681471.000
-94756.000
-1847959.000
2284353.000
-2363010.000
-2363010.000
11
Tax Expense
12
13
'f!:!P
ii.r
r !1 /&ft'
I
Extraordinary items
Share of profit (loss) of associates

Profit (loss) of minority interest
Net Profit (loss) after taxes minority interest and share of profit (loss) of associates
AHME
--- ---
-1581312.000
10
.
.
c;l
12254601.000
&
:..>#41GJl

CIN: L24231GJ1995PLC024809
Registered Office: 206, Shanti Arcade, Near Akash-111, 132ft. Ring Road, Naranpura, Ahmedabad- 380 013.
Website: www.swordnshieldpharma.com
STATEMENT OF AUDITED FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED MARCH 31,2016
[Amount in (Rs.))
,,
>:e h
.
3 months ended
Particulars
(dd-mm-yyyy)
Previous 3 months
ended
(dd-mm-yyyy)
ponding 3
I*
n .,._
Year to date figures
Year to date figures
months ended in
tor current period
forprevious period
the previous year
ended
ended
(dd-mm-yyyy )
(dc:i-mm-yyyy)
Cor:
F (dd-mm-yyyy)
Preious
-a
ccounting
year ended
(dd-mm-yyyy)
Date of start of reporting quarter
01-01-2016
01-10-2015
01-01-2015
01-04-2015
01-04-2014
01-04-2014
Date of end of reporting quarter
31-03-2016
31-12-2015
31-03-2015
31-03-2016
31-03-2015
31-03-2015
Audited
Unaudited
Audited
Audited
Audited
Audited
Standalone
Standalone
Standalone
Standalone
Standalone
Standalone
Whether results are audited or unaudited
22
Details of equity share capital
24
26
i
ii
Paid-up equity share capital
46619170.000
46619170.000
46619170.000
46619170.000
46619170.000
Face value of equity share capital
10.000
10.000
10.000
10.000
10.000
10.000
Reserves excluding revaluation reserve
-47818349.000
-47818349.000
-45455339.000
-47818349.000
-45455339.000
-45455339.000
46619170.000
Earnings per share

Earnings per share before extraordinary items
Basic earnings per share before extraordinary items
0.790
-0.020
-0.400
0.490
-0.570
-0.570
Diluted earnings per share before extraordinary items
0.790
-0.020
-0.400
0.490
-0.570
-0.570
Earnings per share after extraordinary items

Basic earnings per share after extraordinary items
0.790
-0.020
-0.400
0.490
-0.570
-0.570
Diluted earnings per share after extraordinary items
0.790
-0.020
-0.400
0.490
-0.570
-0.570
Notes:
'
The above Audited Financial Results were reviewed by the Audit Committee of the Board and approve and taken on record by the Board of Directors of the Company at its meeting held on 30th May, 2016.
The Company has only one segment of Activity.
The figures of the Last Quarter are the Balancing figure between the Audited figures in respect of the full Financial Year ended 31st March,2016 and unaudited published year to date figures up to the Third Quarter ended 31st
The figures of the previous period have been regrouped or rearranged wherever necessary to make them comparable with current figures.
Date :
May 30,2016
Place:
Ahmedabad
>oc '"' o:
,,
:-
:t!
.JJ'*' C7 - :
&
'GJ1
Mr. Pravinb
Oboc,
atel
Managing Director
DIN: 01877446

CIN:L24231GJ1995PLC024809
Registered Office: 206, Shanti Arcade, Near Akash-111, 132 ft. Ring Road, Naranpura, Ahmedabad - 380 013.
Website : www.swordnshieldpharma.com
Statement of Asset and Liabilities

Particulars
1\
\.
Current year ended
Previous year ended
(dd-mm-yyyy)
(dd-mm-yyyy)
Date of start of reporting period
01-04-2015
01-04-2014
Date of end of reporting period
31-03-2016
31-03-2015
Whether results are audited or unaudited

Audited
Audited
Standalone
Standalone
Equity and liabilities

1
Shareholders' funds
Share capital
Res":.rves and_urpls
--
-'
46619170.000
46619170.000
-45S33996.000
-47818349.000
Money received against share warrants

Total shareholders' funds
,.,_
- -N-,
0.000
0.000
1085174.000
-1199179.000
hare app!ication _r:noney pe_nd_0.g alh:>tment
0.000
Deferred government grants
0.000
0.000
Minority interest
0.000
0.000
Non-current liabilities
3957500.000
6557500.000
0.000
0.000
0.000
--
Long-term borrowin.gs
Deferred tax liabilities (net)
1-
--
Foreign currency monetary item translation difference liability account
0.000
0.000
Other long-ter_m liabilities
0.000
0.000
Long-term provisions
0.000
0.000
3957500.000
6557500.000
-N
,_
--
Total non-current liabilities
Current liabilities
S?rt-term borrowings
Trade payab--
0.000
__
0.000
45163.000
Other current liabilities
2033038.000
Short-term provisions
576669.000
6163714.000
40300.000
10177.000
Total current liabilities
2118501.000
6750560.000
Total equity and liabilities
7161175.000
12108881.000
Tangible asets
0.000
7521040.000
Producing properties
0.000
Intangible assets
0.000
Assets
Non-current assets
Fixed assets
(i)
'"
.fproducing propertis
--
Tangible assets capital work-in-progress
Total fixed assets

(ii)
Non-current investments
(iii)
Goodwill on consolidation
(v)
Deferred tax assets (net)
(vi)
Foreign currency monetary item translation difference asset account
(vii)
Long-term loans and advances
(viii)
Other non-current assets
'
0.000
0.000
0.000
0.000
0.000
7521040.000
0.000
0.000
0.000
0.000
1024359.000
1024359.000
0.000
0.000
--
0.000
Total non-current assets
0.000
0.000
0.000
Intangible assets under development or work-in-progress
--
0.000
0.000
0.000
0.000
1024359.000
8545399.000
Current assets
Current investments
0.000
Inventories
678391.000
Cash and bank balances

-
494170.000
Short-term loans and advances
1476720.000
u;.,c:,\\':lf4.o
7
1
.
-IGJ1
*
594438.000
957685.000
0.000
0.000
Total current assets
6136816.000
3563482.000
Total assets
7161175.000
12108881.000
Other current assets
;;;::.olio,
0.000
-----
534639.000
4964255.000
Trade receivables
- -
--
0.000
,.
B. K. PATEL & CO
Chartered Accountants
Opp. Old High Court, Navjivan P.O., AHMEDABAD- 380 014. Gujarat.
301, 'SAMRUOOHI',
PHONES
079- 2754 4927, 2754 1151. FAX- 079 2754 1151
kpateloodco@gmoi!
com
Email ; b
Auditor's Report
on Quarterly Financial Results and Year to Date Results of the Company
(Pursuant to the Regulation 33 of the SEBI (Lis ti ng Obligations and Disclosure Requirements) Regula tions, 2015)
To,
Board of Directors,
SWORD AND SHIELD PIIARMA LJMJTED.

We have audited the quanerly frnancial results o f
SWORD MD SHIELD
PJJARMA LIMITED for the
q u arter ended March 31,2016 and the year to date results for the period April 1, 2015 to March 31,2016,
atta ched herewith. being submitted by the company pursuant to the requireme nt of Regulation
SEBI (Lis ting
33
or the
Obligations and Di sc l osure Requirements) Regulations, 2015. These quarterly financial
results as well as the year
to
date financial results ha ve bee n pre pared on the basis of the interim financial
statements, which are the responsibility of the company's management. Our responsibility is to express an
opinion on the se financial re sults based on our audit of such interim financial statements, which have been
prepared in accordance with the recogniti on and measurement princip les laid down in Accounting Standard
for Interim Financial Reporting (AS 25 I Tnd AS
34),
prescrbed, under Section 133 of the

i
Companies Act,
2013 read with relevant rules issued thereunder; or by the Institute of Chartered Accountants of India,
as
applic a ble and other accounting pr n

ciples generally accepted in India.
i
We conducted our audit in accordance with the auditing standards generally accepted in India. Those
standards require that we plan and pcrfonn the audit to obtain reasonable assurance about whether the
financial results
are
free of material miss ta tement(s) . An audit includes exam ining,
supporting the amounts disclosed as financial results. An audit also includes
on
a test basis, evidence
assesis ng
the accounting
pr inc iples used and significant estimates made by management. We believe that our audit prov ides a
reasonable basis for our opinion.
In our opinion and to the best of our information and
according
to the explanations given
to
us these
q u arterly financial results as well as the year to date results:
(i)
are
presented in accordance with the requi rements of Regulation 33 of the
SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015 in th is regard; and

(ii) give a true and fair view of the net profit and other financial infonnation for the quaner ended March
31,2016 as well as the year to date results for the period from April I, 2015 to March 31,2016.
For, B. K. PATEL& CO
Chartered Accountants
FRN: 112647W
3052016
Ahmedabad
Par 1er
Membership No. : 039 1 9
Date: May 30, 2015

FORMA
(for Audit Report with unmodified Opinion)
[Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure

Requirements) Regulations, 2015]
1.
2.
Name of the Company

Annual Financial for the year
ended
SWORD AND SHIELD PHARMA LIMITED
March
31, 2015
3.
Type ofObservation
Un-qualified
4.
Frequency ofObservation
Not Applicable
5.
To be Signed by:
Mr. Pravinbhai Patel

Managing Director
(DIN:
01877446)
Mfs. B. K. Patel & Co.

Chartered Accountants.
(Auditor of the Company)
Mr. Jayeshkumar Patel

Audit Committee Chairman

Standalone Financial Results, Form A, Auditors Report For March 31, 2016 (Result)

Hochgeladen von

Dokumentinformationen

Originaltitel

Copyright

Verfügbare Formate

Dieses Dokument teilen

Dokument teilen oder einbetten

Freigabeoptionen

Stufen Sie dieses Dokument als nützlich ein?

Sind diese Inhalte unangemessen?

Copyright:

Verfügbare Formate

Standalone Financial Results, Form A, Auditors Report For March 31, 2016 (Result)

Hochgeladen von

Copyright:

Verfügbare Formate

s?"Sword & Shield Pharma Ltd.

CIN: L24231 GJ1995P C024809

Date: May 30, 2016.

Phiroze Jeejeebhoy Towers,

SWORD AND SHIELD PHARMA LTD

Year'tO date figures

Year t9:date figures

for current period

for previous period

the previous year

Date of start of reporting quarter

Date of end of reporting quarter

Whether results are a'udited or unaudited

Nature of report standalone or consolidated

Revenue From Operations

Net sales or Revenue from Operations

Other operating revenues

Total Revenue from operations (net)

Cost of materials consumed

Changes in inventories of finished goods, work-in-progress and stock-in-trade

Employee benefit expense

Depreciation and amortisation expense

Total other expenses

Profit (loss) from ordinary activities before tax

Net profit (loss) from ordinary activities after tax

Net Profit loss for the period from continuing operations

Profit (loss) from discontinuing opertions before tax

Tax expense of discontinuing operations

Net profit (loss) from discontinuing operation after tax

Profit (loss) for period before minority interest

Share of profit (loss) of associates

SWORD AND SHIELD PHARMA LTD

Year to date figures

Year to date figures

tor current period

the previous year

Date of start of reporting quarter

Date of end of reporting quarter

Whether results are audited or unaudited

Nature of report standalone or consolidated

Details of equity share capital

Paid-up equity share capital

Face value of equity share capital

Reserves excluding revaluation reserve

Earnings per share

Diluted earnings per share before extraordinary items

Earnings per share after extraordinary items

Diluted earnings per share after extraordinary items

The Company has only one segment of Activity.

SWORD AND SHIELD PHARMA LTD

Statement of Asset and Liabilities

Current year ended

Previous year ended

Date of start of reporting period

Date of end of reporting period

Whether results are audited or unaudited

Equity and liabilities

Money received against share warrants

hare app!ication _r:noney pe_nd_0.g alh:>tment

Deferred government grants

Foreign currency monetary item translation difference liability account

Other long-ter_m liabilities

Total non-current liabilities